View in EDS

Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial.

Saved in:
Bibliographic Details
Title: Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial.
Authors: Henderson, Michael A1,2 michael.henderson@petermac.org, Burmeister, Bryan H3, Ainslie, Jill4, Fisher, Richard5, Di Iulio, Juliana5, Smithers, B Mark3, Hong, Angela6, Shannon, Kerwin6, Scolyer, Richard A6, Carruthers, Scott7, Coventry, Brendon J7, Babington, Scott8, Duprat, Joao9, Hoekstra, Harald J10, Thompson, John F6
Source: Lancet Oncology. Sep2015, Vol. 16 Issue 9, p1049-1060. 12p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 109181031
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Henderson%2C+Michael+A%22">Henderson, Michael A</searchLink><relatesTo>1,2</relatesTo><i> michael.henderson@petermac.org</i><br /><searchLink fieldCode="AR" term="%22Burmeister%2C+Bryan+H%22">Burmeister, Bryan H</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Ainslie%2C+Jill%22">Ainslie, Jill</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Fisher%2C+Richard%22">Fisher, Richard</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Di+Iulio%2C+Juliana%22">Di Iulio, Juliana</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Smithers%2C+B+Mark%22">Smithers, B Mark</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Hong%2C+Angela%22">Hong, Angela</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Shannon%2C+Kerwin%22">Shannon, Kerwin</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Scolyer%2C+Richard+A%22">Scolyer, Richard A</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Carruthers%2C+Scott%22">Carruthers, Scott</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Coventry%2C+Brendon+J%22">Coventry, Brendon J</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Babington%2C+Scott%22">Babington, Scott</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Duprat%2C+Joao%22">Duprat, Joao</searchLink><relatesTo>9</relatesTo><br /><searchLink fieldCode="AR" term="%22Hoekstra%2C+Harald+J%22">Hoekstra, Harald J</searchLink><relatesTo>10</relatesTo><br /><searchLink fieldCode="AR" term="%22Thompson%2C+John+F%22">Thompson, John F</searchLink><relatesTo>6</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Lancet+Oncology%22">Lancet Oncology</searchLink>. Sep2015, Vol. 16 Issue 9, p1049-1060. 12p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=109181031
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S1470-2045(15)00187-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 12
        StartPage: 1049
    Titles:
      – TitleFull: Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Henderson, Michael A
      – PersonEntity:
          Name:
            NameFull: Burmeister, Bryan H
      – PersonEntity:
          Name:
            NameFull: Ainslie, Jill
      – PersonEntity:
          Name:
            NameFull: Fisher, Richard
      – PersonEntity:
          Name:
            NameFull: Di Iulio, Juliana
      – PersonEntity:
          Name:
            NameFull: Smithers, B Mark
      – PersonEntity:
          Name:
            NameFull: Hong, Angela
      – PersonEntity:
          Name:
            NameFull: Shannon, Kerwin
      – PersonEntity:
          Name:
            NameFull: Scolyer, Richard A
      – PersonEntity:
          Name:
            NameFull: Carruthers, Scott
      – PersonEntity:
          Name:
            NameFull: Coventry, Brendon J
      – PersonEntity:
          Name:
            NameFull: Babington, Scott
      – PersonEntity:
          Name:
            NameFull: Duprat, Joao
      – PersonEntity:
          Name:
            NameFull: Hoekstra, Harald J
      – PersonEntity:
          Name:
            NameFull: Thompson, John F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: Sep2015
              Type: published
              Y: 2015
          Identifiers:
            – Type: issn-print
              Value: 14702045
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Lancet Oncology
              Type: main
ResultId 1